January 1, 2017Thrombosis and Haemostasis
NOACs for treatment of venous thromboembolism in clinical practice
View Full Paper
Ask AI
Bookmark
Share
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Real-world registry data on NOAC adherence and QoL in VTE may inform decisions; leaves open need for confirmatory trials.
Structured PICO
I
Intervention
non-vitamin K antagonist oral anticoagulants (NOACs)
This review discusses the role and limitations of observational studies in evaluating the real-world efficacy, safety, and patient-reported outcomes of NOACs for VTE treatment.
Cite This Study
Schulman et al. (2017) studied this question.
Topics
View Full Paper
Ask AI
Bookmark
Share